Prostaglandin I2 (PGI2), a potent vasodilator and inhibitor of platelet aggregation, is a major product of arachidonic acid metabolism in endothelial cells that are derived from large blood vessels (e.g., umbilical veins). We have examined whether PGI2 is also a major product of arachidonic acid metabolism in cultured endothelial cells that are derived from dermal microvessels in human newborn foreskin. Supernatants from confluent monolayers of endothelial cells that had been incubated for 20 min with [3H]arachidonic acid and the calcium ionophore A23187 (10 microM) were assayed for prostaglandin F2 alpha (PGF2 alpha), prostaglandin E2 (PGE2), and 6-keto-prostaglandin F1 alpha (PGF1 alpha) (the stable metabolite of PGI2) by using authentic standards and high performance liquid chromatography. Whereas supernates from stimulated umbilical vein endothelial cells contained 6-keto-PGF 1 alpha much greater than PGF 2 alpha much greater than PGE2, supernates from stimulated foreskin microvessel endothelial cells contained PGF 2 alpha congruent to PGE2 much greater than 6-keto-PGF 1 alpha. Similar results were obtained when supernates from stimulated, unlabeled endothelial cells were analyzed by radioimmunoassay. These data indicate that PGI2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels.
Prostaglandin 12 Is Not a Major Metabolite of Arachidonic Acid in Cultured Endothelial Cells from Human Foreskin Microvessels olite of PGI2) by using authentic standards and high performance liquid chromatography. Whereas supernates from stimulated umbilical vein endothelial cells contained 6-keto-PGFia > PGF2a. > PGE2, supernates from stimulated foreskin microvessel endothelial cells contained PGF2a _ PGE2 > 6-keto-PGFIa. Similar results were obtained when supernates from stimulated, unlabeled endothelial cells were analyzed by radioimmunoassay. These data indicate that PGI2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels.
Introduction
Endothelial cells, which line the walls of both large and small blood vessels, normally present a nonthrombogenic surface to circulating blood. Prostaglandin I2 (PGI2)' is a major product of arachidonic acid metabolism in endothelial cells that are derived from large blood vessels (e.g., human umbilical veins) (1, 2) . PGI2 may play a role in preventing thrombus formation by inhibiting both platelet aggregation (1, 2) and attachment of platelets to endothelial surfaces (3) . Since microvascular endothelial cells differ from large vessel endothelial cells with respect to their morphology, growth characteristics, and ability to activate prothrombin in vitro (4-6), we have examined whether PGI2 is also a major product of arachidonic acid metabolism in these cells. We have found that cultured endothelial cells derived from dermal microvessels in human foreskin synthesize almost no PGI2. Instead, the major products of arachidonic acid metabolism in these microvascular endothelial cells are prostaglandins F2. and E2 (PGF2. and PGE2).
Methods
Endothelial cell cultures. Calcium-and magnesium-free Hanks' balanced salt solution (CMF-Hanks), Medium 199, Iscove's medium, fetal calf serum, N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes buffer), penicillin, streptomycin, and trypsin were obtained from Gibco Laboratories, Grand Island, NY. Endothelial cells from freshly obtained human umbilical veins were isolated and cultured by using minor modifications of the methods described previously by Jaffe et al. (7) . Cells were detached by incubating umbilical veins for 45 min with sterile CMF-Hanks, pH 7.4, that contained 3.0 mg/ml trypsin and 1.0 mg/ml ethylenediaminetetraacetate (EDTA) (Sigma Chemical Co., St.
Louis, MO). Incubation with trypsin yielded as many viable endothelial cells as incubation with collagenase and was considerably less costly.
Detached endothelial cells were sedimented at 250 g for 10 min, washed once, and resuspended in Medium 199, supplemented with 20% (vol/vol) fetal calf serum, 25 mM Hepes buffer, pH 7.4, 100 U/ml penicillin, 100 ug/ml streptomycin, and 100 ng/ml fibroblast growth factor (FGF) (generously provided by Dr. Denis Gospodarowicz, University of California, San Francisco). Primary cultures were established in 35-mm diam plastic Petri dishes (Falcon Plastics, Oxnard, CA) that had been coated previously with fibronectin (0.05 mg/dish), which was prepared from plasma by the method of Engvall and Ruoslahti (8) . Plating density was -2.5 X 105 cells/dish. Primary cultures were provided with fresh medium every 48 h, and grown to confluence at 370C in an environment of 5% CO2 and 100% humidity (usually 3-5 d). For subculture, cells were harvested by brief treatment (4 min, 370C) with EDTA (0.2 mg/ml)-trypsin (0.5 mg/ml) in CMFHanks, sedimented, washed once, resuspended in fresh medium, and diluted 1:4 before plating (-2.5 X 101 cells/dish).
Endothelial cells from the microvessels of newborn human foreskin were isolated as described by Davison et al. (4) . Foreskin tissue, obtained after routine circumcision, was collected in sterile 150 mM NaCl that contained 400 U/ml penicillin and 200 #g/ml streptomycin.
The epidermis was removed with a Castroviejo keratome (Storz Instrument Co., St. Louis, MO), and the highly vascular region of the dermis was sectioned into 5-mm cubes. These were incubated for 45 min at 37°C with 3.0 mg/ml trypsin in sterile 150 mM NaCl (supplemented with 1.0 mg/ml glucose, 10 mg/ml EDTA, and 0.4 mg/ ml KC1, and adjusted to pH 7.3). After washing the tissue sections three times with 150 mM NaCl, endothelial cells were expressed from small blood vessels into modified Iscove's medium (9) that contained 10% (vol/vol) human (maternal) serum and antibiotics. Cells were pooled, sedimented (800 g for I min), and resuspended in modified Iscove's medium supplemented with 10% (vol/vol) human (maternal) serum, antibiotics, and 0. (4) . Because of the relatively small yield of microvessel endothelial cells, plating density for primary cultures was -3 X 104 cells/dish. Primary cultures were provided with fresh medium every 72 h and maintained at 371C (6% C02, 100% humidity) until they were confluent (-5-7 d). Modified Iscove's medium containing 10% (vol/vol) maternal serum was as effective as the medium reported previously (i.e., minimal essential medium that contained 50% (vol/ vol) pooled human serum) (4) for supporting growth ofthe microvascular endothelial cells. For subculture, cells were harvested with EDTAtrypsin (see above), sedimented, washed once, resuspended in fresh medium, and diluted 1:4 before plating (-2.0 X 105 cells/dish). Only confluent monolayers of either primary or early-passage endothelial cells (5-7 d after isolation or passage) were used in the experiments described below.
By using only the highly vascular region of the dermis as a source of microvessel endothelial cells, contamination of primary cultures with either fibroblasts or keratinocytes (easily recognized by their characteristic morphology) was minimal. Substantially longer and more vigorous treatment of dermal tissue with trypsin is required to release fibroblasts. Furthermore, proliferation of fibroblasts in primary cultures is inhibited in medium that contains cAMP (10) . When contamination was observed in primary cultures, microvessel endothelial cells were separated from fibroblasts and keratinocytes by brief treatment with EDTA-trypsin and replated. Only confluent cultures containing cells that exhibited a homogeneous cobblestone morphology were used in the experiments described below (Fig. 1) . In representative cultures, >95% of the umbilical vein and dermal microvessel endothelial cells stained positively for Factor VIII antigen by indirect immunofluorescence (4) (Fig. 2) High performance liquid chromatography (HPLC). Reverse-phase HPLC was performed by using an Ultrasphere-ODS C18 column (5 WM, 4.7 mm X 25 cm) and precolumn (4.7 mm X 3 cm) (Rainin Instrument Co., Emeryville, CA). Lipids were eluted isocratically at a flow rate of 1.0 ml/min with acetonitrile/water/acetic acid (65:35:1). HPLC fractions (1.0 ml) were analyzed for radioactivity by liquid scintillation counting after mixing with 10 ml Aquasol 2 (New England Nuclear). In experiments performed to calibrate the column, recoveries of tritiated PG standards were >95%.
Radioimmunoassays (RIA). Confluent monolayers of umbilical vein and foreskin microvessel endothelial cells (8-9 X l0s and 7-8 X 10 per dish, respectively) were preincubated for 10 min with and without 10 MuM indomethacin (Sigmal Chemical Co.) before exposure for 20 min to either A23187 (10 MM), human a-thrombin (5.0 U/ml) (provided by Dr. J. W. Fenton, II, Dept. of Health, Albany, NY), or unlabeled arachidonic acid (10 MM) (Nu-Chek Prep, Inc., Elysian, MN). Supernates were assayed for 6-keto-PGF1,, PGF2a, and PGE2 by RIA as described previously (13), by using antisera from Seragen Inc., Boston, MA, and tritiated PG standards. There was >35% binding of radiolabeled antigen in all assays, and the lower limit of detection was 50 pg (0.5 ng/ml). Total cell DNA was measured by the method of Labarca and Paigen (14) .
In some experiments, culture supernates were extracted and subjected to HPLC before RIA. RIA was performed on aliquots of l.0-ml HPLC (Fig. 3 A) . These results are similar both qualitatively and quantitatively to those reported previously by others (1, 2, 15, 16). In contrast, barely detectable amounts of [3H]6-keto-PGFIa were recovered from supernates of identically treated foreskin microvessel endothelial cells (Fig. 3 B) cells was recovered intact after incubation for 20 min with or without A23187. Thus, our inability to detect 6-keto-PGFI, in supernates from stimulated microvessel endothelial cells most likely was due to failure of these cells to synthesize this compound, and not simply due to either binding or catabolism of 6-keto-PGFI. by the endothelial cells.
Analysis by RIA. Supernates from confluent monolayers of umbilical vein endothelial cells that had been incubated for 20 min with either A23187, a-thrombin, or arachidonic acid contained 6-keto-PGFI, PGF2, > PGE2 (measured by RIA) ( Table I) . Identical results were obtained with umbilical vein endothelial cells that had been grown in Iscove's medium that contained human serum and cAMP (not shown). In contrast, only very small amounts of 6-keto-PGF1. were detected by RIA in supernates from similarly treated foreskin microvessel endothelial cells. Rather, PGF2. and PGE2 were the major products of arachidonic acid metabolism in these stimulated cells. In response to A23187, for example, microvessel endothelial cells generated approximately the same amount of PGE2 as umbilical vein endothelial cells, but less than 'A5th as much 6-keto-PGFIa. Levels of 6-keto-PGFIa, PGE2, and PGF2a were undetectable (<0.5 ng/ml) in supernates from both umbilical vein and microvessel endothelial cells that had been stimulated in the presence of 10 AM indomethacin (not shown).
To confirm the specificity of the RIA and to increase the likelihood of detecting synthesis of 6-keto-PGFIa, supernates from stimulated microvessel endothelial cells were analyzed by RIA after extraction and HPLC. None of the HPLC fractions at or near the retention time of authentic 6-ketoPGFIc contained detectable amounts of this arachidonic acid metabolite (Fig. 4) . Again, the major products detected were PGF2. and PGE2.
Discussion
Results of our studies indicate that, unlike endothelial cells derived from large blood vessels, human foreskin microvessel endothelial cells synthesize little, if any, PG12 in vitro. Whereas umbilical vein endothelial cells synthesized abundant amounts (Fig. 4) . Furthermore, since the antiserum used to measure 6-keto-PGFia appeared to cross-react with PGF2,. and PGE2, it is likely that analyses of whole culture supernates by RIA (Table I) Isolated capillaries from guinea pig and rat brain also synthesize much less 6-keto-PGFIa than either PGE2, PGF2., or prostaglandin D2 (18) . Finally, Coughlin et al. (19) detected only very small amounts of 6-keto-PGFI in supernates of stimulated bovine adrenal microvessel endothelial cells (as compared with bovine aortic endothelial cells).
Although it has been proposed (20) that synthesis of PGI2 by endothelial cells is crucial for preventing platelet adherence to blood vessel walls and platelet aggregation, this remains unproven. Indeed, recently summarized evidence (21) suggests that this may not be the case. Our findings that cultured microvessel endothelial cells have only a limited capacity to synthesize PGI2 suggest that this arachidonic acid metabolite may not play a critical role in regulating hemostasis in the microvasculature.
